The US diabetes care device market will grow strongly through 2028, fueled by an expanding diabetes patient population in the country, the launch of new and innovative products, as well as the adoption of premium-priced technologies, particularly in the insulin pumps market.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for diabetes care devices in the US across a 10-year period.
The US diabetes care device market will grow strongly through 2028.
How does growth vary between product segments?
What are the factors driving the market expansion?
Numerous new competitors are expected to enter this space within the forecast period.
Who are these competitors and what products are they bringing to the market?
Which segments are seeing the most incoming competitors?
Several products within the diabetes care device space have gained Medicare coverage in recent years.
Which products and companies have benefited from this?
What other companies are also seeking to gain approval for coverage of their product from CMS?
- Diabetes Care Devices - Market Insights - United States
Author(s): Lucy Sha Guan, MSc
Lucy Guan is a senior analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, with extensive knowledge in the markets for endoscope servicing, video and high-tech hardware devices, and laparoscopic devices. Lucy holds an Honors Bachelor's degree in Biochemistry and Health & Disease and a Master's degree in Medical Science from the University of Toronto.